About NAD Prescribed

What this publication is

NAD Prescribed is an independent editorial project that publishes summaries of the peer-reviewed research literature on NAD+ and its precursors. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — a reading of the record, filed like a newspaper's research desk.

Why "Prescribed"

The word in our name is editorial framing, not a service. "Prescribed" here means what the literature prescribes as evidence — the doses trials actually used, the routes the studies actually tested — not a prescription pad, a pharmacy, or a telehealth funnel. NAD+ is not a prescription medicine; it is an endogenous coenzyme sold, when sold at all, as a dietary supplement, and most often as a precursor. We file the research record on it. We do not prescribe, dispense, or sell, and there is no clinic behind this masthead.

How we handle the evidence

Three rules govern every page. First, we keep the coenzyme distinct from its precursors: a trial of oral NMN or NR is never described as "taking NAD+," because the molecule and its building blocks are not the same thing. Second, every quantitative claim carries a citation to a named, published study, resolved on the references page to its PubMed record. Third, we describe only what specific studies measured — "in a randomized trial, X mg/day of NMN raised blood NAD+" — and never recommend a dose or a course of use for any person.

Where the evidence is strong, we say so plainly: oral precursors reliably raise blood NAD+. Where it is thin — the injectable route, the hard clinical endpoints, the contested NMN supplement status — we file it under the caution desk in plain view rather than the footnotes. The aim is a sober, accurate reading a curious non-scientist can follow and a careful reader can trust.